|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Anesthesiology (Drs. Nakagawa and Kishi) and Cancer Control and Statistics (Drs. Tanaka and Tsukuma), Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka City, Japan.
Correspondence to: Masashi Nakagawa, MD, Department of Anesthesiology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi Higashinari, Osaka City, 537-8511, Japan; e-mail: m.h.naka{at}f4.dion.ne.jp
| Abstract |
|---|
|
|
|---|
Design: Retrospective cohort study.
Setting: Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
Patients: Two hundred eighty-eight consecutive patients who underwent pulmonary surgery between January 1997 and December 1998.
Measurements and results: We collected information on the preoperative characteristics, intraoperative conditions, and occurrence of PPCs by reviewing the medical records. Study subjects were classified into four groups based on their smoking status. A current smoker was defined as one who smoked within 2 weeks prior to the operation. Recent smokers and ex-smokers were defined as those whose duration of abstinence from smoking was 2 to 4 weeks and > 4 weeks prior to the operation, respectively. A never-smoker was defined as one who had never smoked. The incidence of PPCs among the current smokers and recent smokers was 43.6% and 53.8%, respectively, and each was higher than that in the never-smokers (23.9%; p < 0.05). The moving average of the incidence of PPCs gradually decreased in patients whose smoke-free period was 5 to 8 weeks or longer. After controlling for sex, age, results of pulmonary function tests, and duration of surgery, the odds ratios for PPCs developing in current smokers, recent smokers, and ex-smokers in comparison with never-smokers were 2.09 (95% confidence interval [CI], 0.83 to 5.25), 2.44 (95% CI, 0.67 to 8.89), and 1.03 (95% CI, 0.47 to 2.26), respectively.
Conclusions: These findings indicate that preoperative smoking abstinence of at least 4 weeks is necessary for patients who undergo pulmonary surgery, to reduce the incidence of PPCs.
Key Words: postoperative pulmonary complications preoperative care pulmonary surgery smoking cessation.
| Introduction |
|---|
|
|
|---|
ences in its definition and study population. PPCs still remain a significant problem in clinical practice, despite recent remarkable advances in anesthesia and surgical care.3
Many studies have identified factors associated with an increased risk for PPCs. The chief risk factors are advanced age,4 5 6 7 cigarette smoke,4 5 8 9 obesity,4 10 type of surgery,1 4 7 8 type of anesthesia,4 7 8 abnormal chest radiographic finding,1 8 chronic cough,1 4 7 8 history of pulmonary disease,1 4 7 8 and history of cardiac disease.8 These factors are helpful in identifying patients at high risk for developing PPCs; however, most of these factors are not helpful in reducing the occurrence of PPCs because the factors are not likely to change in a patient.
Smoking cessation is well-known to be one of the most important preoperative preparations prior to any type of surgery; however, the relationship between the duration of preoperative smoking abstinence and beneficial effect on postoperative complications is not clear. Only a few reports have focused on the relationship between a change in smoking habit and the incidence of PPCs. Warner et al11 examined the relationship between the timing of preoperative smoking cessation and the incidence of PPCs in patients who underwent coronary artery bypass graft surgery and reported that a smoke-free period of > 8 weeks was needed to reduce the incidence of PPCs. Bluman et al8 investigated the effect of improvement in smoking status on the incidence of PPCs; however, they only examined whether preoperative reduction in smoking was associated with a reduced risk for PPCs. Thus, limited information is available on the optimal timing of quitting smoking prior to surgery.
The development of PPCs is influenced by many factors;3 thus, further studies are needed to establish the optimal timing of preoperative quitting. The aims of this study are to clarify the relationship between the duration of the preoperative smoke-free period and the incidence of PPCs, and to determine the optimal time at which patients who will undergo a pulmonary surgical procedure should quit smoking.
| Materials and Methods |
|---|
|
|
|---|
Assessment of Preoperative Factors and Smoking Behavior
We collected the following information from the medical records
of each patient: age at hospital admission, sex, height, weight,
American Society of Anesthesiologists (ASA) physical status, and
results of spirometry. To assess whether a patient was overweight, the
body mass index (BMI) was calculated. Information on the smoking habit
was obtained from a self-administered questionnaire on the health
status of the patient at the first visit, from the interview at
hospital admission by nurses, and from the preoperative interview by
the anesthesiologist 1 day or 2 days prior to the surgery. If these
three data were conflicting, we used the worst smoking status, because
most smokers tended to report a better smoking status
The subjects were classified into four groups based on his or her smoking habits. A current smoker was defined as one who had smoked within 2 weeks prior to the operation (n = 37). Past smokers were classified into two groups according to the duration of the smoke-free period. A recent-smoker was defined as one whose duration of smoke-free period was from 2 to 4 weeks prior to the operation (n = 13), and an ex-smoker was defined as one whose duration of smoke-free period was > 4 weeks prior to the operation (n = 121). A never-smoker was defined as one who had never smoked (n = 117).
Assessment of Surgical Procedures
From the surgery records, we obtained information on the type
and duration of the surgical procedure performed on each subject.
According to the extent of the pulmonary surgery, the procedures were
classified into four categories: tumor enucleation (n = 6), wedge
resection (n = 124), lobectomy (n = 146), and pneumonectomy
(n = 12).
Assessment of Postoperative Course
One anesthesiologist who was unaware of the subjects smoking
histories reviewed the medical records of all subjects to determine the
occurrence of PPCs up to the time of hospital discharge. According to a
previous report,5
we defined PPC as development of one or
more of the following events: (1) atelectasis prompting bronchoscopy;
(2) pneumonia defined by radiographic infiltrates plus at least two of
the following: temperature > 37.7°C, WBC count > 10,500/µL,
initiation of antibiotic therapy, and/or demonstration of
pathogenic organisms; (3) PaCO2
> 50 mm Hg at 24 h after the surgery; (4) air leak or effusion
requiring intercostal tube drainage for > 7 days; (5) bronchopleural
fistula with large air leak or infection; (6) empyema; (7) chylothorax;
(8) hemothorax requiring drainage or reoperation; (9) tension
pneumothorax; (10) pulmonary embolism; (11) lobar gangrene; (12)
mechanical ventilation > 72 h for any reason; (13) intercostal tube
drainage > 14 days for any reason; (14) required fraction of inspired
oxygen > 0.6 or alveolar-arterial oxygen gradient > 300 mm Hg 24-h
postoperatively.
Statistical Analysis
Frequency distributions were determined for discriminant
variables and categorized by smoking habit.
2
test was used to compare the distribution of sex, ASA physical status,
pulmonary function tests, and surgical procedures in the subjects by
smoking habit. Continuous data are presented as mean ± SE according
to smoking habit. The Bonferroni multiple comparison technique was
performed to compare the age, BMI, smoking consumption, and duration of
surgery in the subjects by smoking habit. The correlation between
stepwise improvement of smoking habit and incidence of PPCs was
examined through calculation of Spearmans correlation coefficient by
ranks. Logistic regression analysis was used to estimate the odds
ratios (ORs) of PPCs for smoking habit and PPCs, controlling for
potential confounders. In these analyses, p < 0.05 was considered to
be statistically significant. The statistical analyses were performed
using software (SPSS version 7.5; SPSS; Chicago, IL).
The 4-week moving averages were calculated to examine the relationship between the length of the preoperative smoke-free period and the incidence of PPCs. Because the numbers of subjects belonging to each week of abstinence duration were too small and variation of incidences in each week was large, the moving average was employed for smoothing such large variation.
| Results |
|---|
|
|
|---|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Only limited information on the effect of smoking cessation on the incidence of PPCs has been available. Warner et al11 examined the effect of smoking cessation in coronary artery bypass graft surgery patients and reported that abstinence of > 8 weeks prior to the surgery was needed to reduce the incidence of PPCs. Taking the results of the study by Warner et al11 and the present study into consideration, abstinence from smoking of at least 4 weeks, and ideally > 8 weeks, is recommended as preoperative preparation for elective surgery.
Not only long-term but also short-term smoking cessation seems to provide many benefits: prompt reductions in the carboxyhemoglobin and nicotine blood levels, and gradual improvement of mucociliary function and upper-airway hypersensitivity12 and respiratory symptoms. The finding that the incidence of PPCs decreased as the duration of the preoperative smoke-free period increased may be due to these biological improvements after smoking cessation.
Many perioperative factors have been reported as risk factors for PPCs besides smoking.1 4 5 6 8 10 The results of the univariate analysis were compatible with previous reports. In the present study, we classified study subjects into four groups according to the subjects smoking status. The baseline demographics and characteristics of the four groups were similar except for sex, results of pulmonary function tests, and duration of surgery. Thus, multivariate analysis was performed to control these differences.
The adjusted ORs of both the current smokers and recent smokers were > 2, which indicates a moderately increased risk13 in comparison with the never-smokers, although neither difference was statistically significant. In this study, the numbers of current smokers and recent smokers were small compared with the numbers of ex-smokers and never-smokers. The power of detecting a difference among groups, therefore, seemed weak in this study.
Cigarette smoking is a risk factor for not only PPCs, but also other complications after surgery. Short-term exposure to cigarette smoke reduces the efficacy of the pulmonary immune defense due to impairment of alveolar macrophage function14 ; it also increases the ST-segment depression due to elevation of the blood carbon monoxide concentration.15 Moreover, cigarette smoking increases the risk for perioperative myocardial infarction in patients undergoing a major nonvascular abdominal operation.16 Therefore, smoking cessation should be encouraged for reducing these complications.
A limitation of this study is the definition of smoking status. We did not confirm the smoking status of the patients using biological monitoring techniques such as expired carbon monoxide concentration or nicotine metabolite monitoring. Some current smokers may have declared their smoking status as recent smokers or ex-smokers to medical practitioners, resulting in misclassification in our study. We consider, however, that this misclassification would have overestimated the risk for PPCs among recent smokers and ex-smokers; in other words, this misclassification would have underestimated the effect of preoperative smoking cessation on the incidence of PPCs in the present analysis.
| Conclusion |
|---|
|
|
|---|
| Footnotes |
|---|
This work was performed at Osaka Medical Center For Cancer and Cardiovascular Diseases.
Received for publication November 13, 2000. Accepted for publication March 21, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Murin Smoking Cessation Before Lung Resection Chest, June 1, 2005; 127(6): 1873 - 1875. [Full Text] [PDF] |
||||
![]() |
R. Barrera, W. Shi, D. Amar, H. T. Thaler, N. Gabovich, M. S. Bains, and D. A. White Smoking and Timing of Cessation: Impact on Pulmonary Complications After Thoracotomy Chest, June 1, 2005; 127(6): 1977 - 1983. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Lawrence Predicting Postoperative Pulmonary Complications: The Sleeping Giant Stirs Ann Intern Med, November 20, 2001; 135(10): 919 - 921. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |